Prostatakræft

Research output: Contribution to journal › Review › Research › peer-review

Standard

Prostatakræft. / Borre, Michael; Brodersen, John Brandt; Jacobsen, Henrik; Søndergaard, Jimmi; Poulsen, Mads Hvid; Røder, Andreas.

In: Ugeskrift for Laeger, Vol. 185, No. 14, 2023.

Research output: Contribution to journal › Review › Research › peer-review

Harvard

Borre, M, Brodersen, JB, Jacobsen, H, Søndergaard, J, Poulsen, MH & Røder, A 2023, 'Prostatakræft', Ugeskrift for Laeger, vol. 185, no. 14. <https://content.ugeskriftet.dk/sites/default/files/2023-03/V10220588_WEB.pdf>

APA

Borre, M., Brodersen, J. B., Jacobsen, H., Søndergaard, J., Poulsen, M. H., & Røder, A. (2023). Prostatakræft. Ugeskrift for Laeger, 185(14). https://content.ugeskriftet.dk/sites/default/files/2023-03/V10220588_WEB.pdf

Vancouver

Borre M, Brodersen JB, Jacobsen H, Søndergaard J, Poulsen MH, Røder A. Prostatakræft. Ugeskrift for Laeger. 2023;185(14).

Author

Borre, Michael ; Brodersen, John Brandt ; Jacobsen, Henrik ; Søndergaard, Jimmi ; Poulsen, Mads Hvid ; Røder, Andreas. / Prostatakræft. In: Ugeskrift for Laeger. 2023 ; Vol. 185, No. 14.

Bibtex

@article{9f0f619c2c2245ff89fc9d94a66c3dce,
title = "Prostatakr{\ae}ft",
abstract = "This review investigates prostate cancer which with approx. 4,500 new cases annually is the most frequent male cancer, and the incidence is expected to increase due to demographic developments. Prostate cancer can have a natural history without progression to symptomatic or fatal disease, which is why overdiagnosis is one of the disease's biggest challenges. In contrast to potential curable localized clinically significant disease, this is not the case after metastasis. Fortunately, new treatments, and not least combinations thereof, have increased both lifespan and quality of life in these patients significantly.",
author = "Michael Borre and Brodersen, {John Brandt} and Henrik Jacobsen and Jimmi S{\o}ndergaard and Poulsen, {Mads Hvid} and Andreas R{\o}der",
year = "2023",
language = "Dansk",
volume = "185",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "14",

}

RIS

TY - JOUR

T1 - Prostatakræft

AU - Borre, Michael

AU - Brodersen, John Brandt

AU - Jacobsen, Henrik

AU - Søndergaard, Jimmi

AU - Poulsen, Mads Hvid

AU - Røder, Andreas

PY - 2023

Y1 - 2023

N2 - This review investigates prostate cancer which with approx. 4,500 new cases annually is the most frequent male cancer, and the incidence is expected to increase due to demographic developments. Prostate cancer can have a natural history without progression to symptomatic or fatal disease, which is why overdiagnosis is one of the disease's biggest challenges. In contrast to potential curable localized clinically significant disease, this is not the case after metastasis. Fortunately, new treatments, and not least combinations thereof, have increased both lifespan and quality of life in these patients significantly.

AB - This review investigates prostate cancer which with approx. 4,500 new cases annually is the most frequent male cancer, and the incidence is expected to increase due to demographic developments. Prostate cancer can have a natural history without progression to symptomatic or fatal disease, which is why overdiagnosis is one of the disease's biggest challenges. In contrast to potential curable localized clinically significant disease, this is not the case after metastasis. Fortunately, new treatments, and not least combinations thereof, have increased both lifespan and quality of life in these patients significantly.

M3 - Review

C2 - 37057694

AN - SCOPUS:85152375084

VL - 185

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 14

ER -

ID: 366379776